SEC FORM 4

SEC FORM 4 SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Coric Vlad

(Last)

(First)

(Middle)

C/O VERADERMICS, INCORPORATED

470 JAMES ST.

(Street)

NEW HAVEN

06513

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Veradermics, Inc [ MANE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/03/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	02/05/2026		C⁽¹⁾		33,706	A	⁽¹⁾	33,706	I	See Footnote⁽²⁾
Common Stock	02/05/2026		C⁽¹⁾		33,706	A	⁽¹⁾	33,706	I	See Footnote⁽³⁾
Common Stock	02/05/2026		C⁽⁴⁾		148,794	A	⁽⁴⁾	182,500	I	See Footnote⁽²⁾
Common Stock	02/05/2026		C⁽⁴⁾		148,794	A	⁽⁴⁾	182,500	I	See Footnote⁽³⁾
Common Stock	02/05/2026		C⁽⁵⁾		78,075	A	⁽⁵⁾	260,575	I	See Footnote⁽²⁾
Common Stock	02/05/2026		C⁽⁵⁾		78,075	A	⁽⁵⁾	260,575	I	See Footnote⁽³⁾
Common Stock	02/05/2026		C⁽⁵⁾		117,112	A	⁽⁵⁾	129,939	D
Common Stock	02/05/2026		P		58,823	A	$17	319,398	I	See Footnote⁽²⁾
Common Stock	02/05/2026		P		58,823	A	$17	319,398	I	See Footnote⁽³⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Series A Convertible Preferred Stock	⁽¹⁾	02/05/2026		C			33,706	⁽¹⁾	⁽¹⁾	Common Stock	33,706	⁽¹⁾	0	I	See Footnote⁽²⁾
Series A Convertible Preferred Stock	⁽¹⁾	02/05/2026		C			33,706	⁽¹⁾	⁽¹⁾	Common Stock	33,706	⁽¹⁾	0	I	See Footnote⁽³⁾
Series B Convertible Preferred Stock	⁽⁴⁾	02/05/2026		C			148,794	⁽⁴⁾	⁽⁴⁾	Common Stock	148,794	⁽⁴⁾	0	I	See Footnote⁽²⁾
Series B Convertible Preferred Stock	⁽⁴⁾	02/05/2026		C			148,794	⁽⁴⁾	⁽⁴⁾	Common Stock	148,794	⁽⁴⁾	0	I	See Footnote⁽³⁾
Series C Convertible Preferred Stock	⁽⁵⁾	02/05/2026		C			78,075	⁽⁵⁾	⁽⁵⁾	Common Stock	78,075	⁽⁵⁾	0	I	See Footnote⁽²⁾
Series C Convertible Preferred Stock	⁽⁵⁾	02/05/2026		C			78,075	⁽⁵⁾	⁽⁵⁾	Common Stock	78,075	⁽⁵⁾	0	I	See Footnote⁽³⁾
Series C Convertible Preferred Stock	⁽⁵⁾	02/05/2026		C			117,112	⁽⁵⁾	⁽⁵⁾	Common Stock	117,112	⁽⁵⁾	0	D
Stock Option (Right to Buy)	$17	02/03/2026		A		51,525		⁽⁶⁾	02/03/2036	Common Stock	51,525	$0	51,525	D

Explanation of Responses:

1. On February 5, 2026, the shares of Series A Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.00001 per share ("Common Stock"), on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date.

2. Shares held by Vladimir Coric Family Trust 2013.

3. Shares held by Vladimir Coric Marital Trust 2013.

4. On February 5, 2026, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date.

5. On February 5, 2026, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date.

6. This option shall be fully vested and exercisable on February 3, 2027, the first anniversary of the vesting commencement date.

Remarks:

	/s/ Michael Greco, Attorney-in-Fact	02/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.